Charles Schwab’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,726
Closed -$85.6K 3571
2023
Q4
$85.6K Sell
5,726
-1,022
-15% -$42.4K ﹤0.01% 3358
2023
Q3
$429K Hold
6,748
﹤0.01% 3096
2023
Q2
$630K Buy
6,748
+1,298
+24% +$114K ﹤0.01% 2946
2023
Q1
$437K Hold
5,450
﹤0.01% 2995
2022
Q4
$597K Buy
5,450
+51
+0.9% +$7.62K ﹤0.01% 2944
2022
Q3
$1.15M Buy
5,399
+9
+0.2% +$1.82K ﹤0.01% 2747
2022
Q2
$587K Buy
5,390
+4,368
+427% +$749K ﹤0.01% 3013
2022
Q1
$230K Buy
1,022
+214
+26% +$44.4K ﹤0.01% 3282
2021
Q4
$187K Hold
808
﹤0.01% 3370
2021
Q3
$235K Buy
+808
New +$238K ﹤0.01% 3302

Other funds holding CMAX

Charles Schwab's CMAX Position: Q1 2024 in Review

Charles Schwab sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q1 2024, closing a stake of 5,726 shares — an estimated $85.6K sold.

Charles Schwab first reported a position in CMAX in Q3 2021 and held it in 10 quarters. The position peaked at $1.15M in Q3 2022. 42 funds tracked by Wall St. Rank hold CMAX as of Q1 2024.

  • Charles Schwab reported no remaining CareMax, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Charles Schwab sold 5,726 CareMax, Inc. Class A Common Stock shares in Q1 2024, an estimated $85.6K.
  • Charles Schwab first reported a position in CareMax, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
  • Charles Schwab's CareMax, Inc. Class A Common Stock position peaked at $1.15M in Q3 2022.
  • 42 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q1 2024.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.